Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Arrhythmia Market Growth in 2025?

The value of the arrhythmia market has been bolstered significantly in the last few years. The market, which is set to escalate from $7.8 billion in 2024 to $8.35 billion in 2025, is expected to exhibit a compound annual growth rate (CAGR) of 7.0%. This substantial growth in the previous years can be traced back to escalated risk factors associated with lifestyle, a surge in cardiovascular illnesses, enhancements in implantable devices, a worldwide rise in heart surgeries, escalating demand for distance monitoring, as well as R&D efforts in antiarrhythmic medications.

What Is the Forecast for the Arrhythmia Market Size Through 2029?

In the upcoming years, the arrhythmia market is predicted to experience significant growth, escalating to $11.83 billion in 2029 with a compound annual growth rate (CAGR) of 9.1%. The predicted expansion during the forecast period is a result of factors such as increased awareness and education, personalized medical treatments, the proliferation of electrophysiology labs, emphasis on early detection and preventative measures, genetic testing for inherited arrhythmias, and the development of healthcare infrastructure. The primary trends anticipated during this forecast period include progress in cardiac monitoring technology, the rise of telehealth and remote patient care, attention on atrial fibrillation (AF) identification and treatment, implantable gadgets for managing arrhythmia, advances in ECG monitoring equipment, and a regulatory focus on the approval of medical devices.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8018&type=smp

What are the Key Market Players in Arrhythmia Market and How They’re Evolving?

Major companies operating in the arrhythmia market are Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, AliveCor Inc., Biotronik SE & Co. KG, Biotricity Inc., GE Healthcare, Koninklijke Philips N.V., Nihon Kohden Corporation, Spacelabs Healthcare, Welch Allyn Inc., Mylan N.V., Lepu Medical Technology Co. Ltd., iRhythm Technologies Inc., BioTelemetry Inc., Fukuda Denshi Co. Ltd., Smart Solutions Technologies Inc., Biosense Webster Inc., Cardiac Science Corporation, CardioComm Solutions Inc., CardioNet LLC, NUUBO SMART SOLUTIONS S.L., Cardiva Medical Inc., Osypka AG, Johnson & Johnson Services Inc., Pfizer Inc, Teva Pharmaceutical Industries Ltd, Applied Cardiac Systems, Acutus Medical, EP Solutions SA

What Are the Primary Growth Drivers in the Arrhythmia Market?

The escalating incidents of cardiac disease and other heart-related issues are anticipated to boost the expansion of the arrhythmia market in the future. Cardiac disease or cardiovascular disease encompasses a range of conditions affecting the heart and blood vessels, such as atherosclerosis, heart attacks, stroke, and arrhythmia, to name a few. Heart failure, atrial fibrillation, and other cardiovascular diseases are often the result of both functional flaws like diastolic and systolic dysfunction and electrical deviations like the occurrence of arrhythmias. For example, the CDC (Centers for Disease Control and Prevention), a government agency in the United States, reported in October 2022 that annually, approximately 69.7k deaths were due to heart disease and 80.5k people suffered from heart attacks in the US. Therefore, the increase in incidents of cardiac disease and other heart-related afflictions is fuelling the upsurge of the arrhythmia market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=8018&type=smp

What Are the Leading Segments in the Global Arrhythmia Industry?

The arrhythmia market covered in this report is segmented –

1) By Type: Supraventricular Tachycardias, Ventricular Arrhythmias, Bradyarrhythmias, Other Types

2) By Test Equipment: Electrocardiogram (ECG), Holter Monitor

3) By Hearth Blocks: First Degree Heart Block, Second Degree Heart Block, Third Degree Heart Block

4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Supraventricular Tachycardias: Atrial Fibrillation, Atrial Flutter, Paroxysmal Supraventricular Tachycardia (PSVT)

2) By Ventricular Arrhythmias: Ventricular Fibrillation, Ventricular Tachycardia, Premature Ventricular Contractions (PVCs)

3) By Bradyarrhythmias: Sinus Bradycardia, Heart Block

4) By Other Types: Long QT Syndrome, Wolff-Parkinson-White Syndrome, Torsades de Pointes

What Are the Key Market Trends in the Arrhythmia Industry?

The emergence of novel treatment solutions is a significant trend in the arrhythmia market. Leading participants in the market are moving towards the creation of innovative therapies such as cryoablation therapy, an avant-garde treatment for arrhythmia patients. For example, in August 2023, GE HealthCare, a medical technology firm based in the US, introduced CardioVisio for Atrial Fibrillation, a digital, patient-focused clinical decision support application designed to facilitate precision care. CardioVisio employs sophisticated data analytics and patient understandings to assist medical professionals in better comprehending and managing atrial fibrillation, a widespread heart condition. With the provision of personalized care regimens and real-time data monitoring, this tool strives to heighten the precision of treatment decisions and bolster patient results, indicating a considerable progression in cardiac care management.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/arrhythmia-global-market-report

What Is the Regional Outlook for the Arrhythmia Market?

North America was the largest region in the arrhythmia market in 2024. The regions covered in the arrhythmia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8018

This Report Delivers Insight On:

1. How big is the arrhythmia market, and how is it changing globally?

2. Who are the major companies in the arrhythmia market, and how are they performing?

3. What are the key opportunities and risks in the arrhythmia market right now?

4. Which products or customer segments are growing the most in the arrhythmia market?

5. What factors are helping or slowing down the growth of the arrhythmia market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.